Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 04:00:02 2024-05-31 pm EDT			5-day change	1st Jan Change
142 ^USD	+1.89%		+0.49%	+2.97%

May. 30	JPMorgan Adjusts Price Target on Quest Diagnostics to $155 From $152	MT
May. 29	Transcript : Quest Diagnostics Incorporated Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-29-2024 09:20 AM

Quest Diagnostics Incorporated Declares Quarterly Cash Dividend, Payable on July 22, 2024

May 15, 2024 at 05:45 pm EDT

Quest Diagnostics announced that its Board of Directors declared a quarterly cash dividend of $0.75 per share, payable on July 22, 2024 to shareholders of record of Quest Diagnostics common stock on July 8, 2024.

Latest news about Quest Diagnostics Incorporated

JPMorgan Adjusts Price Target on Quest Diagnostics to $155 From $152	May. 30	MT
Transcript : Quest Diagnostics Incorporated Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-29-2024 09:20 AM	May. 29
Declaration of Voting Results by Quest Diagnostics Incorporated	May. 21	CI
Quest Diagnostics Elects Robert B. Carte to Board of Directors	May. 16	CI
Everlasting momentum	May. 16
Argus Research Adjusts Quest Diagnostics Price Target to $215 From $163	May. 16	MT
Baird Adjusts Price Target on Quest Diagnostics to $145 From $144, Keeps Neutral Rating	May. 16	MT
Argus Adjusts Price Target on Quest Diagnostics to $215 From $163, Keeps Buy Rating	May. 16	MT
ANALYST RECOMMENDATIONS : Ecolab, Texas Instruments, Cisco, Britvic, Shopify...	May. 16
Quest Diagnostics Keeps Quarterly Cash Dividend at $0.75 a Share, Payable on July 22 to Shareholders of Record on July 8	May. 15	MT
Quest Diagnostics Incorporated Declares Quarterly Cash Dividend, Payable on July 22, 2024	May. 15	CI
Argus Raises Quest Diagnostics' Price Target to $163 From $155	May. 15	MT
Ontario Municipal Employees Retirement System Reportedly in Advanced Talks to Sell LifeLabs Medical Laboratory Services to Quest Diagnostics	May. 12	CI
Quest Diagnostics Appoints Murali Balakumar as Senior Vice President and Chief Information and Digital Officer	May. 06	CI
Quest Diagnostics to Acquire PathAI Diagnostics Assets in Collaboration Deal	May. 01	MT
Quest Diagnostics Forms Licensing Agreements with PathAI	May. 01	CI
Baird Adjusts Quest Diagnostics' Price Target to $144 From $138	Apr. 30	MT
US FDA publishes final rule for laboratory developed tests	Apr. 29	RE
Labcorp beats quarterly estimates on strong testing demand	Apr. 25	RE
Jefferies Adjusts Price Target on Quest Diagnostics to $160 From $155	Apr. 24	MT
UBS Adjusts Price Target on Quest Diagnostics to $146 From $139, Maintains Neutral Rating	Apr. 24	MT
Barclays Raises Quest Diagnostics' Price Target to $144 From $138	Apr. 24	MT
Deutsche Bank Adjusts Quest Diagnostics Price Target to $136 From $125, Maintains Hold Rating	Apr. 24	MT
Mizuho Adjusts Quest Diagnostics' Price Target to $155 From $150	Apr. 24	MT
Citigroup Adjusts Quest Diagnostics Price Target to $145 From $135	Apr. 24	MT

Chart Quest Diagnostics Incorporated

Duration

Period

More charts

Company Profile

Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (2.7%).

Sector

Healthcare Facilities & Services

Calendar

2024-07-07 - Ex-dividend day

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Quest Diagnostics Incorporated

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

142 USD

Average target price

147 USD

Spread / Average Target

+3.54%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
QUEST DIAGNOSTICS INCORPORATED	+2.97%	15.77B
HCA HEALTHCARE, INC.	+25.52%	88.99B
CVS HEALTH CORPORATION	-24.52%	74.82B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-5.56%	25.03B
FRESENIUS SE & CO. KGAA	+4.31%	17.88B
LABCORP HOLDINGS INC.	-14.25%	16.43B
NATERA, INC.	+70.11%	13.09B
TENET HEALTHCARE CORPORATION	+79.20%	13.21B
DAVITA INC.	+40.44%	12.9B
UNIVERSAL HEALTH SERVICES, INC.	+24.51%	12.7B

Other Healthcare Facilities & Services